[Assessment of a post-emergency pathway with early urological regulation].

Analyse d’un modèle de circuit court post-urgence avec une régulation précoce urologique.

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 08 03 2020
revised: 09 05 2020
accepted: 13 06 2020
pubmed: 16 10 2020
medline: 8 7 2021
entrez: 15 10 2020
Statut: ppublish

Résumé

Urological emergencies represent 7 % of the outpatients at the emergency department (ED). We assessed the effect of setting up a post-emergency consultation (CPU) after deferred urological medical regulation. All patients admitted to the ED in a university center over the period December 2017 to July 2018 and for whom a CPU was scheduled were included. The regulation concerned the date of CPU and supplementary exams. The main outcome was the ability to provide an efficient response according to a predefined grid of specific solutions. One hundred and twenty-eight patients were included. The median age was 57 years (18-97). Efficacy of the CPU was 76 %. This rate was lower in no-show patients or consulting for rare and complex motives (47 %, n=60). The no-show were not reachable on the first call in 51.6 % of cases, with a similar age and motives distribution to the others. Only 6,9 % (n=128) of all consultants (n=1863) had been referred to the CPU by emergency physicians. The decision was a second consultation in 70 % (48), a new exam in 10 % (7), deferred emergency surgery in 12 % (8) and finally 18 % (12) of no follow-up. CPU following early regulation by a urologist provides an effective response in 76 % of situations. Assessment of "no-shows" helped to identify groups at risk. III.

Identifiants

pubmed: 33055003
pii: S1166-7087(20)30211-6
doi: 10.1016/j.purol.2020.06.003
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

1051-1059

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

I Bentellis (I)

Service d'urologie, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France. Electronic address: bentellis.i@chu-nice.fr.

F Colomb (F)

Service d'urologie, CH de Grasse, 28, chemin de Clavary, 06130 Grasse, France.

M Drogrey (M)

Service des urgences, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

B Canac (B)

Service des urgences, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

B Tibi (B)

Service d'urologie, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

Y Ahallal (Y)

Service d'urologie, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

L Mendel (L)

Service d'urologie, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

A Shaikh (A)

Département de recherche clinique, service d'urologie, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

J Amiel (J)

Service d'urologie, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

J Levraut (J)

Service des urgences, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

D Chevallier (D)

Service d'urologie, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

M Durand (M)

Service d'urologie, hôpital Pasteur-2, CHU de Nice, université de Nice-Sophia Antipolis, 30, voie Romaine, 06000 Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH